Showing results (71-80 of 130) with videos related to
Sort By:
Pageof 13
European Journal of Haematology|July 29, 2023
An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literatureYosef Joseph Rene Amel Riazat-Kesh, Alexander Maraveyas, Lily Martin, et al.American Journal of Clinical Pathology|May 5, 2022
The Quantification and Significance of Extramedullary Hematopoiesis Seen on Liver Biopsy SpecimensDouglas Tremblay, Shahram Saberi, John Mascarenhas, et al.The Oncologist|April 1, 2021
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic LeukemiaDouglas Tremblay, Noa Rippel, Jonathan Feld, et al.Leukemia|October 13, 2021
Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor CellsMin Lu, Lijuan Xia, Nada Elmansy, et al.Journal of Thrombosis and Thrombolysis|February 9, 2020
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulationLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.Leukemia Research|March 13, 2022
Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new futureDaniel I Nathan, Jonathan Feld, Siraj M El Jamal, et al.Blood Advances|February 21, 2020
The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosisLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.Inflammatory Bowel Diseases|March 19, 2020
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel DiseaseLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.Virology|February 15, 2005
Cell wall localization of Red clover necrotic mosaic virus movement protein is required for cell-to-cell movementDouglas Tremblay, Andrew A Vaewhongs, Katherine A Turner, et al.International Journal of Molecular Sciences|April 13, 2024
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease ProgressionJoseph Tripodi, Ronald Hoffman, Douglas Tremblay, et al.Pageof 13